Breaking News
3736 - 3750 of 6634 results
Prev
248 249 250 251 252 253 254 255 256 257 258 259 260 261 262 263 264 265 266 267 268 269 270 271 272 273 274 275 276 277 278 279 280 281 282 283 284 285 286 287 288 289 290 291 292 293 294 295 296 297 298 299 300 301 302 303 304 305 306 307 308 309 310 311 312 313 314 315 316 317 318 319 320 321 322 323 324 325 326 327 328 329 330 331 332 333 334 335 336 337 338 339 340 341 342 343 344 345 346 347 348 349 350 351 352 353 354 355 356 357 358 359 360 361 362 363 364 365 366 367 368 369 370 371 372 373 374 375 376 377 378 379 380 381 382 383 384 385 386 387 388 389 390 391 392 393 394 395 396 397 398 399 400 401 402 403 404 405 406 407 408 409 410 411 412 413 414 415 416 417 418 419 420 421 422 423 424 425 426 427 428 429 430 431 432 433 434 435 436 437 438 439 440 441 442 443
Next
November 10, 2009
Pfizer has plans to close six R&D sites and cut an unspecified number of jobs in the U.S. and UK as part of its integration with Wyeth.
Read More »
November 10, 2009
Bristol-Myers Squibb and Alder Biopharmaceuticals, Inc. entered a global agreement for the development and commercialization of ALD518, a biologic that has completed Phase IIa development for the treatment of rheumatoid arthritis.
Read More »
November 10, 2009
Novavax, Inc. initiated a Phase IIa study of its trivalent seasonal influenza VLP vaccine candidate in healthy adults 60 years of age or older.
Read More »
November 9, 2009
Evotec AG and Boehringer Ingelheim have extended their research collabration for four more years.
Read More »
November 6, 2009
Quintiles officially opened its expanded regional headquarters facility in Singapore’s Science Park I.
Read More »
November 6, 2009
Gloucester Pharmaceuticals received approval from the FDA for Istodax (romidepsin) for the treatment of cutaneous T-cell lymphoma (CTCL) in patients who have received at least one prior systemic therapy.
Read More »
November 6, 2009
Ziopharm Oncology, Inc. achieved positive data from the multicenter randomized Phase II trial of palifosfamide (ZymafosTM, ZIO-201) in patients with unresectable or metastatic soft tissue sarcoma.
Read More »
November 5, 2009
Ligand Pharmaceuticals and Pfizer have extended their JAK3 research collaboration for another year.
Read More »
November 5, 2009
Early Stage revenue was $10.8 million (-4%) and YTD was $27.2 million (+7%).
Read More »
November 4, 2009
Merck has completed its merger with Schering-Plough Corp. and has outlined its new global strategy.
Read More »
November 4, 2009
Pramod Gupta, Ph.D. has been appointed vice president of quality and chief scientific officer, Coldstream Laboratories, Inc. (CLI).
Read More »
November 4, 2009
Emerson Resources, Inc. has formed a strategic partnership with Bio Research, a CRO specializing in agrichemical and related industries, to extend its business development capabilities.
Read More »
November 3, 2009
Johnson & Johnson has announced plans for a global restructuring designed to “prioritize its innovation efforts,” according to a company statement.
Read More »
3736 - 3750 of 6634 results
Prev
248 249 250 251 252 253 254 255 256 257 258 259 260 261 262 263 264 265 266 267 268 269 270 271 272 273 274 275 276 277 278 279 280 281 282 283 284 285 286 287 288 289 290 291 292 293 294 295 296 297 298 299 300 301 302 303 304 305 306 307 308 309 310 311 312 313 314 315 316 317 318 319 320 321 322 323 324 325 326 327 328 329 330 331 332 333 334 335 336 337 338 339 340 341 342 343 344 345 346 347 348 349 350 351 352 353 354 355 356 357 358 359 360 361 362 363 364 365 366 367 368 369 370 371 372 373 374 375 376 377 378 379 380 381 382 383 384 385 386 387 388 389 390 391 392 393 394 395 396 397 398 399 400 401 402 403 404 405 406 407 408 409 410 411 412 413 414 415 416 417 418 419 420 421 422 423 424 425 426 427 428 429 430 431 432 433 434 435 436 437 438 439 440 441 442 443
Next
